$100K - $150K(Ladders Estimates)
Cambridge, MA 02138
Industry: Pharmaceuticals & Biotech•
8 - 10 years
Posted 62 days ago
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality, and is now advancing a robust pipeline of investigational RNAi therapeutic medicines, including five programs in late-stage development. In 2018, Alnylam received approval for our first product, the first-ever RNAi therapeutic, by the FDA in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and by the European Medicines Agency in the EU for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. Headquartered in Cambridge, Mass., Alnylam employs over 1,200 people in 18 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work four years in a row (2015-2018) and a Great Place to Work in the U.K. and Switzerland in 2019.
The Bioinformatics group is looking for a Senior Software Engineer to develop, maintain and support web applications and tools utilized by Research and other groups. We look to create in house expertise for the migration of our applications to the cloud, the improvement of our dev-ops approach to application deployment, and the build out of a robust test infrastructure. In addition to helping us meet our technical challenges, this position also provides broad and explicit opportunities for technical leadership and project ownership/management.
Summary of Key Responsibilities
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.
Valid Through: 2019-9-12